Company Xlife Sciences AG BOERSE MUENCHEN
Equities
XLS
CH0461929603
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.8 EUR | -0.48% | -7.52% | -3.69% |
Apr. 23 | Xlife Sciences Posts Higher FY23 Profit; Revenue Falls | MT |
Feb. 29 | Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 13
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Not Allocated
66.0
%
| 1 | 72.8 % | 1 | 66.0 % | -12.81% |
Biotechnologies Therapies
34.0
%
| 0 | 27.2 % | 0 | 34.0 % | +20.11% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -3.85% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Oliver Baumann
CEO | Chief Executive Officer | - | 19-06-30 |
Carl von Halem
DFI | Director of Finance/CFO | - | 21-11-30 |
Alexander Zink
CTO | Chief Tech/Sci/R&D Officer | - | - |
Simone Bonito
ADM | Chief Administrative Officer | - | - |
Frank Ploger
CTO | Chief Tech/Sci/R&D Officer | - | 20-10-31 |
Christian Faber
CMP | Compliance Officer | - | 19-09-11 |
Beat Kläui
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Faber
CMP | Compliance Officer | - | 19-09-11 |
Mark Müller
BRD | Director/Board Member | - | 18-10-24 |
Oliver Baumann
CEO | Chief Executive Officer | - | 19-06-30 |
David Deck
CHM | Chairman | - | 22-06-19 |
Désirée Dosch
BRD | Director/Board Member | - | 22-06-19 |
Norbert Windhab
BRD | Director/Board Member | - | 22-06-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,703,292 | 2,838,803 ( 49.77 %) | 0 | 49.77 % |
Company contact information
Sector
Sales per Business
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.43B | |
+47.81% | 41.69B | |
+9.45% | 41.31B | |
-10.92% | 27.14B | |
+9.32% | 25.28B | |
-24.87% | 18.47B | |
+29.70% | 12.59B | |
+1.28% | 12.33B | |
+7.78% | 11.03B |
- Stock Market
- Equities
- XLS Stock
- XLS Stock
- Company Xlife Sciences AG